Pregnancy Itching and Cholestasis (ICP) in India: When Itchy Palms Need a Bile Acid Test

• ICP is a liver condition, not a skin condition. The itch comes from bile acids building up in your blood, so there is usually no rash to see.
• The classic signature is intense itching of the palms and soles, with no rash, worse at night, starting in the late second or third trimester.
• Any persistent third-trimester itching deserves two blood tests: a total bile acid test and a liver function test (LFT). FOGSI guidance is clear on this. Do not let it be brushed off as 'just pregnancy itch'.
• ICP raises the risk of stillbirth, preterm birth and fetal distress, and the risk rises with the bile acid number, climbing sharply at 100 micromoles per litre or higher.
• Treatment is ursodeoxycholic acid (UDCA) tablets to ease the itch and improve bile flow, plus weekly monitoring and a planned, slightly earlier delivery based on the bile acid level.
• The itching and liver tests almost always return to normal within 6 weeks of delivery, but ICP recurs in 60-80% of future pregnancies, so flag it at your next booking visit.

Intrahepatic cholestasis of pregnancy is a problem with your liver, not your skin, and that one fact explains why it is so often missed. In a normal pregnancy, your liver keeps making bile acids and pushing them out through tiny transport channels into your gut, where they help digest fats.

In ICP, the surge of pregnancy hormones in the third trimester, mainly estrogen and progesterone, overwhelms those transport channels in women who carry a genetic susceptibility. The bile acids stop draining properly. Instead of flowing into the gut, they back up into the bloodstream, where they irritate the nerve endings under the skin and cause the relentless itch.

Because the trouble is in your blood and not on your skin, there is usually nothing to see: no rash, no redness, no scaling. The skin looks normal. What you feel does not match what the doctor sees, which is exactly why a rushed clinic can dismiss it. You may develop scratch marks on your shins and forearms from scratching, but those are a result of the itch, not the cause.

The genetic part has been traced to variants in two bile-transport proteins, BSEP and MDR3, the molecular pumps that move bile acids out of the liver. These variants lower the pump's reserve, which is why ICP runs in families. Even so, it can appear in a woman with no family history and no obvious risk factors, so the symptom pattern itself is always the most important clue.

Worldwide, ICP affects roughly 0.5% to 1.5% of pregnancies. In Indian women the rate runs towards the higher end of that range, and higher still in some communities, the Sindhi and Punjabi populations in particular, with certain Gujarati groups also showing elevated rates. The reason is a higher background frequency of the susceptibility variants in BSEP and MDR3 in these ancestral groups, exposed by the universal hormone load of pregnancy.

A few practical factors push the risk up further. If you had ICP in a previous pregnancy, it returns in 60-80% of future pregnancies. A twin or multiple pregnancy carries a heavier hormone load and a higher ICP rate. If you once developed itching or jaundice on an estrogen-containing combined contraceptive pill, you may carry the same underlying susceptibility. A personal history of gallstones, or a family history of cholestatic liver disease, are further markers.

None of these are required for the diagnosis. A first-time mother with no family history can still develop ICP, and many do. The risk-factor list is useful for deciding when to test early, but it should never be turned around to dismiss ICP just because you do not fit the high-risk picture. ICP is one of several third-trimester conditions, alongside Preeclampsia in Pregnancy: High BP, Warning Signs and Care and gestational diabetes, where Indian women benefit from a lower threshold to test.

• Intense itching that starts on the palms of your hands and the soles of your feet before spreading. This palms-and-soles pattern is the single most distinctive feature of ICP and the one that should make a doctor think of cholestasis rather than ordinary pregnancy itch or eczema.
• No rash to show for it. Apart from your own scratch marks, the skin looks normal, with no redness or scaling. The absence of a rash is one of the most reliable ways to tell ICP apart from eczema, prickly heat and the common pregnancy rash known as polymorphic eruption.
• Itch that is worse at night, often badly disrupting sleep. Night-time worsening is so typical it is almost a defining feature.
• Darker urine, occasionally pale stools, and rarely a faint yellow tint to the whites of the eyes can appear when bile acids are higher. But many women have severe itching with normal urine colour and no jaundice at all, so these signs being absent does not rule ICP out.
• Vague discomfort under the right ribs, unusual tiredness, or a general sense of feeling off can accompany the itch and reflect the liver involvement, though none of these alone confirm the diagnosis.
• Onset is usually from about 28 weeks, in the late second or third trimester, but it can start earlier. Early onset should not be used to rule ICP out if the pattern fits.

ICP gets serious attention not because of the itching, distressing as that is, but because high maternal bile acids raise the risk to the baby. The headline concern is stillbirth, and the risk tracks the total bile acid number. At mild levels (10 to 39 micromoles per litre) the stillbirth risk is only slightly above that of a routine pregnancy. At moderate levels (40 to 99) it rises in a measurable way. At severe levels (100 or higher) it rises sharply, which is why the team plans delivery several weeks before 40 weeks rather than letting the pregnancy run on.

Three other risks rise alongside it. Preterm birth is more common, partly because doctors deliberately plan an earlier delivery and partly because spontaneous early labour also seems more frequent in ICP. You can read more in our guide to preterm labour and premature birth. Meconium-stained amniotic fluid, where the baby passes its first stool before birth, is more frequent. And fetal distress in labour, with the baby's heart rate showing strain on the monitor, is also more likely, which is why women with ICP are watched more closely during labour.

The point of laying out the risks is not to frighten you. At mild and moderate levels the absolute risk stays small, and the modern approach, UDCA plus weekly monitoring plus a planned earlier delivery, has greatly improved outcomes compared with decades past. The point is to explain why the diagnosis is taken seriously, why the bile acid level is rechecked weekly, and why delivery is not allowed to drift past its planned window.

The everyday reality is that ICP is often missed or diagnosed late in busy Indian antenatal clinics. The familiar story: a woman mentions itching at one or two visits, is told itching is normal in pregnancy, is handed a calamine lotion or an antifungal cream without any blood test, and is only investigated properly once the itch becomes severe enough to wreck her sleep, or after a second opinion. Some women cycle through dermatologists and physicians for a 'skin problem' before an obstetrician with a higher index of suspicion finally orders the bile acid test.

The Federation of Obstetric and Gynaecological Societies of India (FOGSI), the country's apex obstetric body, addressed this gap directly: persistent third-trimester itching should trigger both a liver function test and a total bile acid test before being written off as ordinary pregnancy itch. The LFT (roughly Rs 400 to Rs 1,500 at private labs, widely available) usually shows raised ALT and AST in established ICP, though a normal LFT does not rule ICP out, because bile acids can rise before the liver enzymes do. The total bile acid test (roughly Rs 800 to Rs 2,500) is the definitive investigation. It is less common at small labs but is reliably run by larger reference labs and major centres such as AIIMS, KEM Hospital, Apollo and Fortis.

The diagnostic cutoff is a total bile acid level above 10 micromoles per litre at most labs (some Indian labs use 15). That number then guides everything: how often bile acids are rechecked, whether UDCA is started, how closely the baby is monitored, and when delivery is planned. The standard workup also rules out look-alikes, viral hepatitis (hepatitis B surface antigen and anti-hepatitis C antibody), preeclampsia (blood pressure and urine protein), and HELLP syndrome (full blood count and clotting). Because preeclampsia can also raise liver enzymes and shares the same third-trimester timing, our guide to high blood pressure and preeclampsia in pregnancy is a useful companion read, as is home BP monitoring if your readings are borderline.

• Total bile acid test (also called serum bile acids). The single most important and specific test for ICP. Roughly Rs 800 to Rs 2,500, less common at small labs but reliably run by reference labs and larger hospitals. A result above 10 micromoles per litre at most labs is the diagnostic cutoff.
• Liver function test (LFT). Roughly Rs 400 to Rs 1,500 and widely available. Usually shows raised ALT and AST in ICP, but a normal LFT does not rule it out, because bile acids can rise before the liver enzymes.
• Hepatitis B surface antigen and anti-hepatitis C antibody, done at the same time, to rule out viral hepatitis. Its management is completely different from ICP.
• Blood pressure and a urine dipstick for protein, to rule out preeclampsia, which can also disturb liver tests but is dominated by high BP and protein in the urine.
• Full blood count (platelets) and a clotting profile, to rule out HELLP syndrome, a pregnancy emergency that must be told apart from ICP because its management is urgent and different.
• Weekly repeat bile acid testing once ICP is confirmed, because the number guides treatment intensity and delivery timing and can shift across the late third trimester. For how these results sit within your wider antenatal reports, see our scans, labs and reports guide.

The first-line and best-established treatment for ICP is ursodeoxycholic acid, almost always shortened to UDCA, a naturally occurring bile acid that improves bile flow out of the liver and eases the itch. In India it is sold as Udcell, Ursofalk and Udimast in 300 mg tablets, roughly Rs 250 to Rs 800 per 7-day strip. The usual obstetric dose is 300 mg two to three times a day, adjusted by your doctor based on your bile acid level and response, and increased up to about 20 mg per kg of body weight per day in more severe cases under specialist supervision.

UDCA helps in three ways. It usually reduces the itching within the first one to two weeks. It lowers the bile acid level and liver enzymes back towards normal over the following weeks. And recent reviews suggest it may modestly reduce stillbirth risk, though the size of that benefit is still debated, so the medicine is not a substitute for the standard practice of a planned earlier delivery in moderate and severe cases. Side effects are generally mild, mostly occasional loose stools.

Because UDCA takes a week or two to work, and some itch lingers even on treatment, comfort measures matter too. Antihistamines such as cetirizine or hydroxyzine help only a little, since this itch is not driven by histamine, but they are widely used and can take the edge off, especially at night. Cool compresses on the palms and soles in the evening, calamine lotion, oatmeal baths, and a cool, well-ventilated room all give practical relief. Wear loose, breathable cotton rather than tight synthetics. Try to resist scratching where you can, as the skin damage from prolonged scratching can take weeks to heal even after the ICP itself is treated.

Do not start any new herbal or over-the-counter remedy without clearing it with your obstetrician. Some herbal products can themselves injure the liver and make the picture worse.

• Mild ICP (bile acids 10 to 39 micromoles per litre): usually a planned delivery between 37 and 39 weeks, at or just before term, because the stillbirth risk at this level is only slightly above background and the baby's lung maturity is the main consideration.
• Moderate ICP (bile acids 40 to 99): usually a planned delivery between 36 and 37 weeks, because the stillbirth risk rises once bile acids cross 40, and the balance tips towards delivering a slightly less mature baby to avoid the higher in-womb risk.
• Severe ICP (bile acids 100 or higher): usually a planned delivery between 34 and 36 weeks, because the stillbirth risk at this level rises sharply and clearly favours earlier delivery, even though prematurity becomes a real consideration.
• Induction of labour is the usual route, not a planned caesarean. ICP on its own is not a reason for a C-section, and a normal vaginal delivery is entirely possible. Our guide to induction of labour in India explains what to expect.
• Monitoring in the run-up to delivery usually includes a weekly non-stress test (CTG) to check the baby's heart-rate pattern, a weekly bile acid recheck, and ultrasound checks of growth and amniotic fluid as your doctor advises. If growth slows, see our guide to intrauterine growth restriction.
• The plan is always individualised. A woman with bile acids rising week on week, a previous unexplained stillbirth, or worsening symptoms may be delivered earlier than the standard window for her category. Your obstetrician's judgement and the specifics of your case always take precedence over a textbook number.

• Any itching in the third trimester that lasts more than a week, involves the palms or soles, or wakes you at night: ask for a total bile acid test and an LFT. Do not wait for it to get worse.
• Itching with darker urine, pale stools, or any yellowing of the eyes or skin: get checked promptly, as these point to higher bile acids or a liver problem.
• If you already have an ICP diagnosis and notice reduced or changed baby movements: contact your maternity unit the same day and go in for monitoring. Never wait until the next morning.
• Severe headache, vision changes, upper-abdominal pain, or sudden swelling of the face and hands alongside itching: these can signal preeclampsia or HELLP and need same-day review. Our guide to swelling and edema in pregnancy covers how to tell harmless swelling from a warning sign.
• If your obstetrician dismisses persistent itching without testing: ask directly for the bile acid test, ask for the result number in writing, and seek a referral to a higher centre if needed.

The itching and abnormal liver tests of ICP almost always settle within the first 6 weeks after delivery. The hormonal trigger is gone, the bile-transport channels return to their non-pregnant workload, and bile acids fall back to normal. A repeat LFT and bile acid level at the 6-week postpartum visit confirm full recovery. If the abnormalities have not resolved by then, that is the cue for a referral to a liver specialist (hepatologist) to look for an underlying chronic liver condition, such as primary biliary cholangitis, that the pregnancy may have unmasked rather than caused. For the wider picture of healing after birth, see what happens after delivery.

ICP recurs in 60-80% of future pregnancies, consistently across the global and Indian literature. This is one of the most important things to carry forward to your next booking visit. Your next obstetrician will start with a higher index of suspicion, arrange an early baseline LFT and bile acid level, and monitor more closely through the late second and third trimester rather than waiting for severe itching.

Worth raising early: family planning. Estrogen-containing combined pills can occasionally trigger cholestasis-like symptoms in women with the underlying susceptibility, so the usual advice is to prefer a progestin-only pill, the progestin-only injection, or a copper or hormonal intrauterine device. If you are breastfeeding, our guide to contraception while breastfeeding covers the safe options and timing. A history of ICP does not rule out future pregnancies at all, but the next one should be planned with this history disclosed and treated as higher-risk from the first visit.

The single most useful thing you can do in suspected ICP is to ask for the bile acid test by name. In an overworked clinic with five-minute consultations, a brief mention of itching is easy to wave away with a calamine lotion. The conversation changes when you specifically ask for a total bile acid test and a liver function test. A simple script: 'My itching has been there for over a week, it started on my palms and soles, it is worse at night, and I would like a total bile acid test and an LFT to rule out cholestasis of pregnancy before we put it down to normal itch.'

If your doctor agrees, the next step is to ask for the actual result number, not just a verbal 'everything is fine'. The bile acid number is the most important data point in your plan, and it should appear on a written or digital lab report you can keep and show to a second opinion if needed. If your doctor declines or is dismissive, ask for a referral to a higher centre, a district hospital, a teaching hospital, or a major tertiary centre such as AIIMS, Apollo or Fortis, where the test is routine and the threshold to order it is lower.

ASHA workers, ANMs and anganwadi workers do valuable community work, but they do not have the equipment or protocol to test for ICP, so a reassuring comment from them should not end the conversation. You are entitled to push the question up the chain, to the medical officer at the primary health centre, the obstetrician at the community health centre, and the specialist at the district hospital, until you get the test. The Pradhan Mantri Surakshit Matritva Abhiyan day on the 9th of each month at government hospitals is a useful low-cost touch-point to request it, and for hospitalisation in severe cases, Ayushman Bharat (PM-JAY) coverage is often available at empanelled hospitals for eligible women. For more on being heard, see our guide on advocating for yourself when doctors don't listen.

• Royal College of Obstetricians and Gynaecologists (RCOG) — Intrahepatic Cholestasis of Pregnancy (Green-top Guideline No. 43)
• NHS — Itching and intrahepatic cholestasis of pregnancy (obstetric cholestasis)
• Ovadia C, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers (individual patient data meta-analysis). The Lancet, 201931877-4/fulltext)
• American College of Obstetricians and Gynecologists (ACOG) — Skin Conditions During Pregnancy
• Federation of Obstetric and Gynaecological Societies of India (FOGSI)